In accordance with Article 185 of the Withdrawal Agreement and Article 5(4) of the Protocol on Ireland/Northern Ireland, Union legislation on medicinal products apply in Northern Ireland after the end of the transition period.
Recital 4, Regulation (EU) 2021/457
In forcesince 13 Jan 2021